Pretransplant Hyponatremia Could Be Associated With a Poor Prognosis After Liver Transplantation
Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. Aim To study the survival rates of recipients who undergo liver transplantation in associatio...
Saved in:
Published in | Transplantation proceedings Vol. 42; no. 10; pp. 4119 - 4122 |
---|---|
Main Authors | , , , , , |
Format | Journal Article Conference Proceeding |
Language | English |
Published |
Amsterdam
Elsevier Inc
01.12.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. Aim To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates. Methods This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m2 ), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors. Results Hyponatremic patients displayed shorter survival ( P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age. Conclusion Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates. |
---|---|
AbstractList | Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates.
To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates.
This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m(2)), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors.
Hyponatremic patients displayed shorter survival (P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age.
Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates. Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. Aim To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates. Methods This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m2 ), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors. Results Hyponatremic patients displayed shorter survival ( P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age. Conclusion Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates. INTRODUCTIONPredicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates.AIMTo study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates.METHODSThis retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m(2)), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors.RESULTSHyponatremic patients displayed shorter survival (P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age.CONCLUSIONHyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates. Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing overall mortality rates. To study the survival rates of recipients who undergo liver transplantation in association with hyponatremia rates. This retrospective study used a prospectively collected database. The characteristics of liver donors and recipients were: age (years), Model for End-stage Liver Disease (MELD), MELD Na score, recipient body mass index (kg/m 2), warm ischemia time (minutes), cold ischemia time (minutes), intensive care unit time (days), hemocomponents transfused, recipient glycemia (mg/dL) and serum sodium (mEq/L), Child-Pugh-Turcotte classification (points), and survival time (months). We analyzed all 318 consecutive liver transplantations from February 1994 to May 2010 divided into two groups: A (Na > 130 mEq/L) and B (Na ≤ 130 mEq/L). The Kaplan-Meier method was used to evaluate survival rate and the Cox regression test to identify predictive factors. Hyponatremic patients displayed shorter survival ( P = .04). The Cox regression for survival time showed that patients with low serum sodium values (group B) had: Child-Pugh scores with 1.13% plus risk of death for each point; cold ischemia time with 1.001% less risk of death for each minute; glycemia with 0.6% for each mg/dL; 0.66% use of cell-saver; plus a risk of death for each 100 mL plus 1.02% risk of death for each year of donor age. Hyponatremic cirrhotic patients show more advanced stages of disease compared to normonatremic cirrhotics. They usually display metabolic or cirrhotic decompensation and comorbidities. When these symptoms were associated with the use of extended criteria donors, increased cold ischemia time, and intraoperative bleeding, we observed lower survival rates. |
Author | Boin, I.F.S.F Caruy, C.A Capel, C Ataide, E.C Cardoso, A.R Stucchi, R.S.B |
Author_xml | – sequence: 1 fullname: Boin, I.F.S.F – sequence: 2 fullname: Capel, C – sequence: 3 fullname: Ataide, E.C – sequence: 4 fullname: Cardoso, A.R – sequence: 5 fullname: Caruy, C.A – sequence: 6 fullname: Stucchi, R.S.B |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23841958$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21168641$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkkFvEzEQhS1URNPCX0AWEuK0wWPvbtYckEKAtlIkIlHE0TjeWXDY2MH2Vsq_r7dJoeqJiy37vXkz-jRn5MR5h4S8AjYFBvXbzTQF7eIueIPYTjm7E6YM5BMygWYmCl5zcUImjJVQgCirU3IW44blNy_FM3LKAeqmLmFCfqwCHtJ67RK93O-80yng1mq68EPf0g9I5zF6Y3XCln636RfVdOV9oKvgfzofbaTzLmGgS3uTz-u_aTpZ756Tp53uI7443ufk2-dP14vLYvnl4moxXxamgjoVcq0raUpA3SCTvBIoOy2FNvm_61C3vOokGBSStVyIWQ2yAt7hGlpRMQ7inLw55GYsfwaMSW1tNNjnQdAPUTWczWTmwbLz3cFpgo8xYKd2wW512CtgagSsNuohYDUCHrUMOBe_PLYZ1tus3ZfeE82G10eDjkb3XQ4yNv7ziabMozfZ9_HgwwzlxmJQ0Vh0Blsb0CTVevt_87x_FGN662zu_Bv3GDd-CC5jV6AiV0x9HVdi3AhgORjqmbgFINW39w |
CODEN | TRPPA8 |
CitedBy_id | crossref_primary_10_1002_lt_25327 crossref_primary_10_1186_1471_2369_14_269 crossref_primary_10_1210_clinem_dgac685 crossref_primary_10_1097_TXD_0000000000001050 crossref_primary_10_1310_hpj4612_s11 crossref_primary_10_1053_j_ajkd_2012_09_019 crossref_primary_10_1007_s10620_012_2276_3 crossref_primary_10_3390_jcm4010066 crossref_primary_10_1002_cld_630 |
Cites_doi | 10.1002/hep.22418 10.1053/j.gastro.2006.02.017 10.1053/j.gastro.2006.02.010 10.1002/hep.22846 10.1056/NEJMe0805570 10.1002/hep.21412 10.1111/j.1478-3231.2009.01982.x 10.1002/lt.21305 |
ContentType | Journal Article Conference Proceeding |
Copyright | Elsevier Inc. 2010 Elsevier Inc. 2015 INIST-CNRS Copyright © 2010 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: Elsevier Inc. – notice: 2010 Elsevier Inc. – notice: 2015 INIST-CNRS – notice: Copyright © 2010 Elsevier Inc. All rights reserved. |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.transproceed.2010.10.019 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2623 |
EndPage | 4122 |
ExternalDocumentID | 10_1016_j_transproceed_2010_10_019 21168641 23841958 S0041134510016167 1_s2_0_S0041134510016167 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: PIBIC–CNPq |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 123 1B1 1P~ 1~. 1~5 29Q 3O- 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABBQC ABFRF ABJNI ABLJU ABMAC ABMZM ABOCM ABXDB ACDAQ ACGFO ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W J5H K-O KOM L7B M41 MO0 N9A O-L O9- OAUVE OK- OW- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SCC SDF SDG SDP SEL SES SEW SPCBC SSH SSZ T5K UDS WH7 X7M XPP Y6R Z5R ZGI ZXP ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR ZA5 08R AAPBV AAUGY ABPIF ABPTK IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c516t-9ba59c41ea8e09253e9fa93acba5ffead25f91ce390d2337619512feb1d350213 |
IEDL.DBID | .~1 |
ISSN | 0041-1345 |
IngestDate | Fri Oct 25 23:44:43 EDT 2024 Thu Sep 26 17:05:46 EDT 2024 Sat Sep 28 07:55:48 EDT 2024 Sun Oct 22 16:03:44 EDT 2023 Fri Feb 23 02:36:11 EST 2024 Tue Oct 15 22:55:25 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Hydroelectrolytic balance disorder Hyponatremia Prognosis Digestive system Liver Homotransplantation Inorganic element Medicine Metabolic disorder Association Treatment Sodium Surgery Graft Preoperative Liver transplantation |
Language | English |
License | CC BY 4.0 Copyright © 2010 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c516t-9ba59c41ea8e09253e9fa93acba5ffead25f91ce390d2337619512feb1d350213 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://doi.org/10.1016/j.transproceed.2010.10.019 |
PMID | 21168641 |
PQID | 820790410 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_820790410 crossref_primary_10_1016_j_transproceed_2010_10_019 pubmed_primary_21168641 pascalfrancis_primary_23841958 elsevier_sciencedirect_doi_10_1016_j_transproceed_2010_10_019 elsevier_clinicalkeyesjournals_1_s2_0_S0041134510016167 |
PublicationCentury | 2000 |
PublicationDate | 2010-12-01 |
PublicationDateYYYYMMDD | 2010-12-01 |
PublicationDate_xml | – month: 12 year: 2010 text: 2010-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Amsterdam |
PublicationPlace_xml | – name: Amsterdam – name: United States |
PublicationTitle | Transplantation proceedings |
PublicationTitleAlternate | Transplant Proc |
PublicationYear | 2010 |
Publisher | Elsevier Inc Elsevier |
Publisher_xml | – name: Elsevier Inc – name: Elsevier |
References | Ginès, Guevara (bib3) 2008; 48 Londono, Guevara, Rimola (bib9) 2006; 130 Tavakol, Assadi, Frederick (bib6) 2008; 8 Yun, Kim, Benson (bib10) 2009; 49 Angeli, Wong, Watson (bib4) 2006; 44 Biggins, Kim, Terrault (bib7) 2006; 130 Hackworth, Heuman, Sanyal (bib2) 2009; 9 Mascarenhas, Gurakar (bib1) 2009; 5 Boin Ide, Leonardi, Udo (bib8) 2008; 45 Cárdenas, Ginès (bib11) 2008; 359 Cywinski, Mascha, Miller (bib5) 2008; 14 Hackworth (10.1016/j.transproceed.2010.10.019_bib2) 2009; 9 Cárdenas (10.1016/j.transproceed.2010.10.019_bib11) 2008; 359 Cywinski (10.1016/j.transproceed.2010.10.019_bib5) 2008; 14 Yun (10.1016/j.transproceed.2010.10.019_bib10) 2009; 49 Mascarenhas (10.1016/j.transproceed.2010.10.019_bib1) 2009; 5 Ginès (10.1016/j.transproceed.2010.10.019_bib3) 2008; 48 Tavakol (10.1016/j.transproceed.2010.10.019_bib6) 2008; 8 Biggins (10.1016/j.transproceed.2010.10.019_bib7) 2006; 130 Angeli (10.1016/j.transproceed.2010.10.019_bib4) 2006; 44 Boin Ide (10.1016/j.transproceed.2010.10.019_bib8) 2008; 45 Londono (10.1016/j.transproceed.2010.10.019_bib9) 2006; 130 |
References_xml | – volume: 14 start-page: 59 year: 2008 ident: bib5 article-title: Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function publication-title: Liver Transpl contributor: fullname: Miller – volume: 130 start-page: 1135 year: 2006 ident: bib9 article-title: Hyponatremia impairs early post transplantation outcome in patients with cirrhosis undergoing liver transplantation publication-title: Gastroenterology contributor: fullname: Rimola – volume: 48 start-page: 1002 year: 2008 ident: bib3 article-title: Hyponatremia in cirrhosis: pathogenesis, clinical significance and management publication-title: Hepatology contributor: fullname: Guevara – volume: 9 start-page: 1071 year: 2009 ident: bib2 article-title: Effect of hyponatremia on outcomes following orthotopic liver transplantation publication-title: Liver Int contributor: fullname: Sanyal – volume: 130 start-page: 1652 year: 2006 ident: bib7 article-title: Evidence-based incorporation of serum sodium concentration into MELD publication-title: Gastroenterology contributor: fullname: Terrault – volume: 5 start-page: 443 year: 2009 ident: bib1 article-title: Recent advances in liver transplantation for the practicing gastroenterologist publication-title: Gastroenterol Hepatol contributor: fullname: Gurakar – volume: 49 start-page: 1610 year: 2009 ident: bib10 article-title: Impact of pretransplant hyponatremia on outcome following liver transplantation publication-title: Hepatology contributor: fullname: Benson – volume: 44 start-page: 1535 year: 2006 ident: bib4 article-title: Hyponatremia in cirrhosis: results of a patient population survey publication-title: Hepatology contributor: fullname: Watson – volume: 8 start-page: 337 year: 2008 ident: bib6 article-title: Pre-transplant meld score and serum sodium can predict post-transplant complications publication-title: Am J Transplant contributor: fullname: Frederick – volume: 359 start-page: 1060 year: 2008 ident: bib11 article-title: Predicting mortality in cirrhosis—serum sodium helps publication-title: N Engl J Med contributor: fullname: Ginès – volume: 45 start-page: 275 year: 2008 ident: bib8 article-title: The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term publication-title: Arq Gastroenterol contributor: fullname: Udo – volume: 48 start-page: 1002 year: 2008 ident: 10.1016/j.transproceed.2010.10.019_bib3 article-title: Hyponatremia in cirrhosis: pathogenesis, clinical significance and management publication-title: Hepatology doi: 10.1002/hep.22418 contributor: fullname: Ginès – volume: 130 start-page: 1135 year: 2006 ident: 10.1016/j.transproceed.2010.10.019_bib9 article-title: Hyponatremia impairs early post transplantation outcome in patients with cirrhosis undergoing liver transplantation publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.02.017 contributor: fullname: Londono – volume: 130 start-page: 1652 year: 2006 ident: 10.1016/j.transproceed.2010.10.019_bib7 article-title: Evidence-based incorporation of serum sodium concentration into MELD publication-title: Gastroenterology doi: 10.1053/j.gastro.2006.02.010 contributor: fullname: Biggins – volume: 45 start-page: 275 year: 2008 ident: 10.1016/j.transproceed.2010.10.019_bib8 article-title: The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term publication-title: Arq Gastroenterol contributor: fullname: Boin Ide – volume: 49 start-page: 1610 year: 2009 ident: 10.1016/j.transproceed.2010.10.019_bib10 article-title: Impact of pretransplant hyponatremia on outcome following liver transplantation publication-title: Hepatology doi: 10.1002/hep.22846 contributor: fullname: Yun – volume: 359 start-page: 1060 year: 2008 ident: 10.1016/j.transproceed.2010.10.019_bib11 article-title: Predicting mortality in cirrhosis—serum sodium helps publication-title: N Engl J Med doi: 10.1056/NEJMe0805570 contributor: fullname: Cárdenas – volume: 44 start-page: 1535 year: 2006 ident: 10.1016/j.transproceed.2010.10.019_bib4 article-title: Hyponatremia in cirrhosis: results of a patient population survey publication-title: Hepatology doi: 10.1002/hep.21412 contributor: fullname: Angeli – volume: 9 start-page: 1071 year: 2009 ident: 10.1016/j.transproceed.2010.10.019_bib2 article-title: Effect of hyponatremia on outcomes following orthotopic liver transplantation publication-title: Liver Int doi: 10.1111/j.1478-3231.2009.01982.x contributor: fullname: Hackworth – volume: 5 start-page: 443 year: 2009 ident: 10.1016/j.transproceed.2010.10.019_bib1 article-title: Recent advances in liver transplantation for the practicing gastroenterologist publication-title: Gastroenterol Hepatol contributor: fullname: Mascarenhas – volume: 14 start-page: 59 year: 2008 ident: 10.1016/j.transproceed.2010.10.019_bib5 article-title: Association between donor-recipient serum sodium differences and orthotopic liver transplant graft function publication-title: Liver Transpl doi: 10.1002/lt.21305 contributor: fullname: Cywinski – volume: 8 start-page: 337 year: 2008 ident: 10.1016/j.transproceed.2010.10.019_bib6 article-title: Pre-transplant meld score and serum sodium can predict post-transplant complications publication-title: Am J Transplant contributor: fullname: Tavakol |
SSID | ssj0004243 |
Score | 2.013351 |
Snippet | Abstract Introduction Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting... Predicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list thereby reducing... INTRODUCTIONPredicting the prognosis of hepatic cirrhosis is the most accurate method to achieve a fair allocation among the liver transplant waiting list... |
SourceID | proquest crossref pubmed pascalfrancis elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 4119 |
SubjectTerms | Adult Biological and medical sciences Female Fundamental and applied biological sciences. Psychology Fundamental immunology Humans Hyponatremia - physiopathology Liver Transplantation Liver, biliary tract, pancreas, portal circulation, spleen Male Medical sciences Middle Aged Preoperative Period Prognosis Surgery Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the digestive system Survival Rate Tissue, organ and graft immunology |
Title | Pretransplant Hyponatremia Could Be Associated With a Poor Prognosis After Liver Transplantation |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0041134510016167 https://dx.doi.org/10.1016/j.transproceed.2010.10.019 https://www.ncbi.nlm.nih.gov/pubmed/21168641 https://search.proquest.com/docview/820790410 |
Volume | 42 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bb9MwFD6ahpCQEIKNS7hUfkB7Wlh9SZo88NBVTOU29aETezNOYmtBLKmS7KEv_HaOnThlAiQk3qq2Ttx8n30-u985BnhtTKYik5iQZSIOhSmSMIszGmpbrF0jRzJnHv98Hi8vxIfL6HIPFj4Xxtoqh7m_n9PdbD28czI8zZNNWdocX0EpFxF1siW2GeUCwx9y-s2Pnc1DMO-co6H9ti886jxenSsg3keK3uZlnV626s6fg9T9jWrx0Zn-zIu_i1IXnM4ewoNBVZJ53_FHsKerAzicV7iivt6SI-J8nm4D_QDunvpXR6u-bvX2mKx3aVjtsWswVrTeHsLXVaP7H_EdgSDL7cbuuTf6ulRkYc_IJqeaeKB1Qb6U3RVRZFXXDVk1tfXylS2Z2-PIySdrBCHr8WqOGY_h4uzderEMh6MZwjyicRemiHCaC6pVoqcpi7hOjUq5yi3yBtnJIpPSXPN0WjDO7V4JKguDgaHgEcoK_gT2q7rSz4BEOsclGJtlWaaEioukELjIQZXBjWYmKQLgHgu56StwSG9N-yZ_RVBaBO1niGAAMw-b9DmmOCvqdhiiraSyZXIqf6NRAG_HlreYKDHI_NOdJ7dYMnYaxZGwpX0CIJ42Esey_YNGVbq-aSWqsVmK3ZkG8LSn064xpXESC_r8P3v3Au6x0ZDzEva75ka_QlnVZRM3biZwZ_7-4_L8J7JHJOk |
link.rule.ids | 310,311,315,783,787,792,793,4509,23942,23943,24128,25152,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Pb9MwGP00hhBIaIKNH2Fj-IB2WlgdO2ly4NBVTAW6qYdO7GacxBZBLKmS7NALfzufnTjdBEhI3KIkTpy8Z38vzvNngLdapzLUsfaDlEc-13nsp1FKfWWStSvkSGrN4-cX0eySf7oKr7Zg6ubCGFtl3_d3fbrtrfs9J_3bPFkVhZnjyyllPKRWtkTje3CfG32MpH73c-Pz4IGzzlHfnO4yj1qTV2sziHehovN5GauXSbvz5yj1eCUbfHe6W_Ti76rURqezJ7DTy0oy6Wr-FLZUuQt7kxI_qa_X5IhYo6cdQd-FB6du62jRJa5eH5PlZh5Wc2wLDCmt13vwdVGr7iF-IBJktl6ZQfdaXReSTM0i2eRUEYe0ysmXov1GJFlUVU0WdWXMfEVDJmY9cjI3ThCyHK5mqfEMLs8-LKczv1-bwc9CGrV-ghAnGadKxmqUBCFTiZYJk5mBXiM9g1AnNFMsGeUBY2awBKWFxsiQsxB1BXsO22VVqpdAQpXhN1gwTtNUchnlcc4RRZQZTKtAx7kHzGEhVl0KDuG8ad_FbQSFQdAcQwQ9GDvYhJtkit2iavo22ggqmkCMxG888uD9UPIOFQVGmX-68-EdlgyVRnXETW4fD4ijjcDGbP7QyFJVN41AOTZOsDojD150dNoUpjSKI05f_Wft3sDD2fJ8LuYfLz7vw6NgcOccwHZb36jXqLHa9NC2oV9JDSaC |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=proceeding&rft.title=Transplantation+proceedings&rft.atitle=Pretransplant+Hyponatremia+Could+Be+Associated+With+a+Poor+Prognosis+After+Liver+Transplantation&rft.au=BOIN%2C+I.+F.+S.+F&rft.au=CAPEL%2C+C&rft.au=ATAIDE%2C+E.+C&rft.au=CARDOSO%2C+A.+R&rft.date=2010-12-01&rft.pub=Elsevier&rft.issn=0041-1345&rft.eissn=1873-2623&rft.volume=42&rft.issue=10&rft.spage=4119&rft.epage=4122&rft_id=info:doi/10.1016%2Fj.transproceed.2010.10.019&rft.externalDBID=n%2Fa&rft.externalDocID=23841958 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00411345%2FS0041134510X00124%2Fcov150h.gif |